Related Experiment Video
Updated: Feb 28, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.7K
Mechanical Circulatory Support in Acute Decompensated Heart Failure and Shock
Nishtha Sodhi1, John M Lasala1
1Cardiovascular Division, Washington University, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Interventional Cardiology Clinics
|June 11, 2017
Summary
Interventional therapies like intra-aortic balloon pumps and ECMO support acute decompensated heart failure and cardiogenic shock. This review covers key mechanical circulatory support options for critical cardiac conditions.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Medical Devices
Background:
- Modern medicine offers various interventional therapeutics for acute and chronic conditions.
- Acute decompensated heart failure and cardiogenic shock are critical medical emergencies requiring immediate intervention.
Purpose of the Study:
- To review interventional therapeutic options for acute decompensated heart failure and cardiogenic shock.
- To discuss the application of intra-aortic balloon pumps, continuous aortic flow augmentation, and extracorporeal membrane oxygenation.
Main Methods:
- Literature review of interventional therapies for acute heart failure and cardiogenic shock.
- Focus on mechanical circulatory support devices.
Main Results:
- Intra-aortic balloon pumps provide hemodynamic support.
- Continuous aortic flow augmentation offers an alternative support strategy.
- Extracorporeal membrane oxygenation (ECMO) provides both respiratory and circulatory support.
Conclusions:
- Mechanical circulatory support devices are crucial in managing acute decompensated heart failure and cardiogenic shock.
- The choice of device depends on the specific clinical scenario and patient needs.
- These interventions represent vital tools in critical cardiac care.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
1.8K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
01:30Heart Failure V: Medical Management
428
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
01:22Heart Failure VI: Adjunct Therapies
474
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
01:30Cardiomyopathy II: Dilated Cardiomyopathy
673
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
673
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
400
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
400